Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Data from this study will contribute additional knowledge regarding patient outcomes and direct somatostatin analogue (SSA) treatment related costs in clinical practice in the Nordic countries. Such knowledge can be of importance in a treatment decision, decision support for development of care, follow up and training of both patients and primary care nurses.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of subjects with injection problems according to the subject | Subject questionnaire asks "In your opinion, how did the last injection go?", subject chooses either 'no problems' or 'problems occurred'. | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of life, mean physical health score in SF-12 derived according to the SF-12 manual. | Mean physical health score and mean mental health score in SF-12 derived according to the SF-12 manual | Day 1 |
| Quality of life, mean mental health score in SF-12 derived according to the SF-12 manual. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Treatment clinic
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ipsen Medical Director | Ipsen | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Skane University Hospital | Lund | 22241 | Sweden | |||
| Uppsala University Hospital |
Not provided
Not provided
Not provided
Not provided
| Day 1 |
| Subject experience: proportion of subjects reporting "much" or "very much" anxiety in subject questionnaire. | Subjects asked "To what extent do you feel anxiety before the injection?" | Day 1 |
| Mean number of packs of H01CB03 and H01CB02 purchased. | Retrospective data collection of a 1 year period |
| Median number of packs of H01CB03 and H01CB02 purchased. | Retrospective data collection of a 1 year period |
| Mean number of two consecutive dispensed prescriptions of H01CB03, H01CB02 within seven days during the pre-specified one-year period of retrospective data extraction. | Retrospective data collection of a 1 year period |
| Median number of two consecutive dispensed prescriptions of H01CB03, H01CB02 within seven days during the pre-specified one-year period of retrospective data extraction. | Retrospective data collection of a 1 year period |
| Median frequency of visits to treating physician in hospital will be derived as number of (frequency) of revisits recorded in the subject questionnaire. | Day 1 |
| Median time - visits to primary care for injections; visits to treating physician at hospital; time to travel | Day 1 |
| Median time for giving injections of SSA in subjects, derived as the time reported in the nurse questionnaire. | Day 1 |
| Proportion of nurses who reported "moderately" or "very" or "very much" confidence in giving injections | Day 1 |
| Uppsala |
| 75185 |
| Sweden |